Brand Owners & Retailers
Aceso Therapeutics
Ecosystem
Private
- Headquarters
- Montpellier, FR
- Segment
- Brand Owners & Retailers
- Stories held
- 0
- Last story
- —
Aceso Therapeutics is a France-based biotech developing ACT-101, an inhaled antisense oligonucleotide candidate targeting the CFTR F508del mutation in cystic fibrosis, building on research from the PhyMedExp laboratory. It is a customer for inhalation device and formulation services from packaging and drug-delivery suppliers such as Aptar Pharma.
No story yet. Stories on this site are written by AI from public sources and checked by a second AI system before they appear; nothing is shown before that check.